Mulham David Mulham's Form 4 filing
Usana Health Sciences Inc (USNA) · filed Aug 15, 2023
- Accession no.
- 0001415889-23-012246
- Filed
- Aug 15, 2023
- Trade date
- Aug 11, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $71.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mulham David MulhamCIK 0001697433 | Officer (CHIEF SALES OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | Common Stock | SSaleDisposed | −1,080 | $66.28F1 | −$71,582.4 | 7,607 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Weighted average price $66.2825. Price range in multiple transactions was $66.26 to $66.30 inclusively.
Referenced by the price of 1 transaction in Table I.